Love what you hear? Download the Curie app from the App Store today.

Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.

In this episode of Curie, Matt delves into three groundbreaking developments. Discover how MRI-guided SBRT is transforming prostate cancer care with fewer side effects. Learn about the FDA’s approval of zanidatamab, a promising therapy for HER2-positive biliary tract cancer. Finally, explore new research highlighting sex-specific risks in MASLD and what it means for patient care. St ...